Investigating immune-epithelial cells in patients with cystic fibrosis

• Conditions: Cystic fibrosi; Mucoviscidosis; 10003816; 10006436

• Registration Number: NL-OMON52014
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 45

Inclusion Criteria

Patients (18-70 years) diagnosed wit cystic fibrosis
Non-smoking for a minimum of 3 months, including cigarettes, marijuana, cigars,
and e-cigarettes/vaping.

Exclusion Criteria

Patients with an active or treated malignancy
Patients who underwent a lung transplant

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Detailed characterization of immune and epithelial cells composition as well as<br /><br>functional properties in peripheral blood, sputum/BAL and tissue biopsy<br /><br>samples. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>